We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
175 result(s) found, displaying 71 to 80
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Prescription medicine decision summaryTGA Decision: Lumakras (sotorasib) is approved to treat adult patients with non-small cell lung cancer (NSCLC).
-
Prescription medicine registrationActive ingredients: sotorasib.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MVASI bevacizumab 100 mg/4 mL injection concentrated vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MVASI bevacizumab 400 mg/16 mL injection concentrated vial.
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd